Janus Henderson Investors US’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Janus Henderson Investors US's AMGN Position: Q1 2017 in Review
Janus Henderson Investors US reduced its Amgen (AMGN) stake by 8.7% in Q1 2017, selling an estimated $100M and leaving 6,333,164 shares worth $1.04B. The position accounts for 0.85% of the portfolio, ranked #11.
Janus Henderson Investors US first reported a position in AMGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.63B in Q4 2015. 1,600 funds tracked by Wall St. Rank hold AMGN as of Q1 2017.
- Janus Henderson Investors US held 6,333,164 shares of Amgen worth $1.04B as of Q1 2017.
- Janus Henderson Investors US sold 603,964 Amgen shares in Q1 2017, an estimated $100M.
- Amgen made up 0.85% of Janus Henderson Investors US's portfolio in Q1 2017, its #11 holding.
- Janus Henderson Investors US first reported a position in Amgen in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's Amgen position peaked at $1.63B in Q4 2015.
- 1,600 funds tracked by Wall St. Rank held Amgen as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.